(Q44197472)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12405293%20AND%20SRC:MED&resulttype=core&format=json

14 December 2019

title

Lovastatin alters cytoskeleton organization and inhibits experimental metastasis of mammary carcinoma cells (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12405293%20AND%20SRC:MED&resulttype=core&format=json

14 December 2019

0 references

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12405293%20AND%20SRC:MED&resulttype=core&format=json

14 December 2019

Daniel Eduardo Gómez

series ordinal

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12405293%20AND%20SRC:MED&resulttype=core&format=json

14 December 2019

author name string

Hernán G Farina

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12405293%20AND%20SRC:MED&resulttype=core&format=json

14 December 2019

Débora R Bublik

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12405293%20AND%20SRC:MED&resulttype=core&format=json

14 December 2019

publication date

1 January 2002

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12405293%20AND%20SRC:MED&resulttype=core&format=json

Clinical & Experimental Metastasis

14 December 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12405293%20AND%20SRC:MED&resulttype=core&format=json

14 December 2019

volume

19

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12405293%20AND%20SRC:MED&resulttype=core&format=json

14 December 2019

issue

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12405293%20AND%20SRC:MED&resulttype=core&format=json

14 December 2019

page(s)

551-559

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12405293%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1023/a:1020355621043

14 December 2019

exact match

0 references

cites work

Inhibition of lung tumor cell growth in vitro and mouse lung tumor formation by lovastatin

1 reference

12 December 2020

Cytoskeleton reorganization induces the urokinase-type plasminogen activator gene via the Ras/extracellular signal-regulated kinase (ERK) signaling pathway

1 reference

12 December 2020

Metastasis of B16F10 mouse melanoma inhibited by lovastatin, an inhibitor of cholesterol biosynthesis

1 reference

12 December 2020

Inhibitory effect of Lovastatin on spontaneous metastases derived from a rat lymphoma

1 reference

12 December 2020

Characterization of F3II, a sarcomatoid mammary carcinoma cell line originated from a clonal subpopulation of a mouse adenocarcinoma

1 reference

12 December 2020

Phase I study of lovastatin, an inhibitor of the mevalonate pathway, in patients with cancer.

1 reference

12 December 2020

Role of urokinase (uPA) and its receptor (uPAR) in invasion and metastasis of hormone-dependent malignancies.

1 reference

12 December 2020

Differential biological significance of tissue-type and urokinase-type plasminogen activator in human breast cancer

1 reference

12 December 2020

Tissue-type plasminogen activator, a new prognostic marker in breast cancer

1 reference

12 December 2020

Relationship of membrane-bound tissue type and urokinase type plasminogen activators in human breast cancers to estrogen and epidermal growth factor receptors

1 reference

12 December 2020

Low cholesterol and cancer

1 reference

12 December 2020

Disruption of the cytoskeleton-extracellular matrix linkage promotes the accumulation of plasminogen activators in F9 derived parietal endoderm

1 reference

12 December 2020

Regulation of intracellular actin polymerization by prenylated cellular proteins

1 reference

12 December 2020

Mevalonate controls cytoskeleton organization and cell morphology in thyroid epithelial cells

1 reference

12 December 2020

Lovastatin-mediated G1 arrest is through inhibition of the proteasome, independent of hydroxymethyl glutaryl-CoA reductase

1 reference

12 December 2020

Lovastatin inhibits tumor growth and metastasis development of a rat fibrosarcoma

1 reference

12 December 2020

Regulation of cytoplasmic division of Xenopus embryo by rho p21 and its inhibitory GDP/GTP exchange protein (rho GDI).

1 reference

12 December 2020

Lovastatin inhibits pancreatic cancer growth regardless of RAS mutation

1 reference

12 December 2020

Suppression of murine neuroblastoma growth in vivo by mevinolin, a competitive inhibitor of 3-hydroxy-3-methylglutaryl-coenzyme A reductase

1 reference

12 December 2020

The mammalian G protein rhoC is ADP-ribosylated by Clostridium botulinum exoenzyme C3 and affects actin microfilaments in Vero cells.

1 reference

12 December 2020

Tumor dormancy induced by downregulation of urokinase receptor in human carcinoma involves integrin and MAPK signaling

1 reference

12 December 2020

Modulation of urokinase-type plasminogen activator and metalloproteinase activities in cultured mouse mammary-carcinoma cells: enhancement by paclitaxel and inhibition by nocodazole

1 reference

12 December 2020

Disruption of cytoskeletal structures results in the induction of the urokinase-type plasminogen activator gene expression.

1 reference

12 December 2020

Role of Rho protein in lovastatin-induced breakdown of actin cytoskeleton

1 reference

12 December 2020

Biology and biochemistry of proteinases in tumor invasion.

1 reference

12 December 2020

Posttranslational modification of proteins by isoprenoids in mammalian cells

1 reference

12 December 2020

In vitro activity of a Solanum tuberosum extract against mammary carcinoma cells

1 reference

12 December 2020

1 reference

12 December 2020

Role of RhoA activation in the growth and morphology of a murine prostate tumor cell line

1 reference

12 December 2020

3-Hydroxy-3-methylglutaryl coenzyme A reductase inhibitors increase fibrinolytic activity in rat aortic endothelial cells. Role of geranylgeranylation and Rho proteins

1 reference

12 December 2020

Effect of cholesterol-free, fat-free diet and hypocholesteremic agents on growth of transplantable animal tumors

1 reference

12 December 2020

Involvement of rho p21 and its inhibitory GDP/GTP exchange protein (rho GDI) in cell motility

1 reference

12 December 2020

Radial caseinolysis in agarose: a simple method for detection of plasminogen activator in the presence of inhibitory substances and serum

1 reference

12 December 2020

Preclinical evaluation of lovastatin

1 reference

12 December 2020

Excessive urokinase-type plasminogen activator activity in the euglobulin fraction of patients with Alzheimer-type dementia.

1 reference

12 December 2020

Amiloride selectively inhibits the urokinase-type plasminogen activator

1 reference

12 December 2020

Control of cell locomotion: perturbation with an antibody directed against specific glycoproteins

1 reference

12 December 2020

3-hydroxy-3-methylglutaryl-coenzyme a reductase inhibitors reduce human pancreatic cancer cell invasion and metastasis

1 reference

12 December 2020

Reduction of mouse mammary tumor formation and metastasis by lovastatin, an inhibitor of the mevalonate pathway of cholesterol synthesis

1 reference

12 December 2020

Lovastatin modulates in vivo and in vitro the plasminogen activator/plasmin system of rat proximal tubular cells: role of geranylgeranylation and Rho proteins.

1 reference

12 December 2020

Role of integrins and other cell adhesion molecules in tumor progression and metastasis

1 reference

12 December 2020

Effects of synthetic urokinase inhibitors on local invasion and metastasis in a murine mammary tumor model

1 reference

12 December 2020

Pharmacology of competitive inhibitors of HMG-CoA reductase.

1 reference

12 December 2020

Modulation of growth and urokinase secretion by vasopressin and closely related nonapeptides in metastatic mouse mammary tumor cells.

1 reference

12 December 2020